Centessa Pharmaceuticals (STU:260) Accounts Payable : €6.90 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Centessa Pharmaceuticals Accounts Payable?

Centessa Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2024 was €6.90 Mil.

Centessa Pharmaceuticals's quarterly Accounts Payable increased from Sep. 2023 (€10.17 Mil) to Dec. 2023 (€10.83 Mil) but then declined from Dec. 2023 (€10.83 Mil) to Mar. 2024 (€6.90 Mil).

Centessa Pharmaceuticals's annual Accounts Payable increased from Dec. 2021 (€7.14 Mil) to Dec. 2022 (€13.06 Mil) but then declined from Dec. 2022 (€13.06 Mil) to Dec. 2023 (€10.83 Mil).

Centessa Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Centessa Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centessa Pharmaceuticals Accounts Payable Chart

Centessa Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

0.85

7.14

13.06

10.83

Centessa Pharmaceuticals Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial										13.42	10.23	10.17	10.83	6.90

Centessa Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Centessa Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Centessa Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Centessa Pharmaceuticals (STU:260) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Centessa Pharmaceuticals PLC (STU:260) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

CNTA:USA

Address

1 Ashley Road, 3rd Floor, Altrincham, Cheshire, GBR, WA14 2DT

Website

https://www.centessa.com

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Centessa Pharmaceuticals (STU:260) Headlines

No Headlines